Correction to: Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma
Badruddoja, Michael A., Pazzi, Marjorie, Sanan, Abhay, Schroeder, Kurt, Kuzma, Kevin, Norton, Thomas, Scully, Thomas, Mahadevan, Daruka, Ahmadi, Michael MalekLanguage:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-017-3448-9
Date:
October, 2017
File:
PDF, 482 KB
english, 2017